-
He has submitted his resignation and will effective at the end of March. I can guarantee this is not a fun job right now with the recalls and all the issues the DePuy division has faced. He’s an executive in charge of running a failing implant division, and personally he did not create the units...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Mar 5 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, FDA, Johnson and Johnson, Orthopedics, Implants, Mergers and Acquisitions, knee, Depuy, hip, Smith & Nephew
-
As you can see from the image below the company has a melanoma drug about ready to submit for on approval and they are working with Roche (Genentech) for the marketing. The skin cancer drug helps sustain life and is an oral medication taken. Daiichi Sankyo is located in Japan and for the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Mar 1 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Biotech, Cancer, FDA, Oncology, Doctors, Japan, melanoma, Mergers and Acquisitions, Daiichi Sankyo, Plexxikon
-
This Merck division was only created about a year ago and Fujifilm is a recent addition to the biotech market with the purchase of another chemical company last year. As mergers and acquisitions go with the use of business intelligence, companies are aligning themselves with “like” or similar technologies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 28 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Biotech, Merck, Heatlhcare, Profits, Mergers and Acquisitions, film medical imaging, Fujifilm
-
This acquisition has been in the news since I believe last August with board rejections and now it appears it has finally resolved and Genzyme will be purchased by Sanofi. This is a huge price tag at $20 Billion. You may or may not be familiar with Genzyme but back in 2009 they were in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 16 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, Massachusetts, Mergers and Acquisitions, Sanofi-Aventis, Genzyme, research and development collaboration
-
Danaher is a conglomerate of companies that have four basic groups. From the website: “Danaher’s business activities encompass four reporting segments and are comprised of seven strategic platforms: Medical Technologies (Life Sciences & Diagnostics and Dental), Professional Instrumentation...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, DNA, healthcare, Biotech, Business Intelligence, software, Code, Algorithms, Mergers and Acquisitions, data warehouse, Beckman Coulter, Beckman, Danaher
-
Just a couple weeks ago, Amgen contracted with Boehringer Ingelheim to take over their Fremont, California location so all employees will now report to Boehringer Ingelheim, which has it headquarters in Germany. BioVex is working on a new approach to treating melanoma and head and neck cancer and...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jan 25 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Cancer, clinical trials, Amgen, Vaccine, Mergers and Acquisitions, stock, transactions, head cancer, melinoma, BioVex, biotechnology
-
Smith and Nephew advertised this year that their knee can last up to 30 years, back in April as it was approved by the FDA. Of course we won’t really know until 29 years from now approximately if they do last that long and for that matter will stem cells and regenerative medicine come in to play...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 17 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, FDA, Johnson and Johnson, Orthopedics, Implants, Mergers and Acquisitions, knee, Depuy, hip, Smith & Nephew
-
The acquisition contains a lot of technology solutions here, if not almost all technology solutions with those algorithms. I guess we are beginning to see this focused everywhere today with modeling physician performance adding additional compensation for the business models. In the text...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Dec 30 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Health IT, McKesson, Cancer, Oncology, Doctors, Patients, Mergers and Acquisitions, US Oncology
-
Montagne has developed many products with their own intellectual property and has obtained some patents. Zimmer as well as a few other knee and hip manufacturers have come under the scrutiny of Congress with their issues here in the US. As referenced in the article, this division is to primarily...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Dec 21 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, China, Orthopedics, Mergers and Acquisitions, hip implant, Zimmer, Beijing Montagne, knee implants
-
NovoLog users can avoid a price spike by switching to another insulin, Humalog per United Healthcare and this is all a shake up of a bidding/contract situation, so who ever comes in at the lower bid moves to the cheap spot at tier 1 and the other ends up at the top level at tier 3, but no tier 2 in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Dec 6 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Medical Devices, FDA, Diabetes, insulin, Heatlhcare, China, UnitedHealthcare, Mergers and Acquisitions, Ingenix, Formularies, tiers, i3, ChinaGate
-
Normally we go and see all the new electronics coming out and this year we have seen a huge blast of new devices in healthcare that not only are for consumers and their own use, but they also are now working with medical records systems that record and report data. This is the changing face of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Oct 29 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, drugs, Medical Devices, FDA, Heatlhcare, China, UnitedHealthcare, Mergers and Acquisitions, Ingenix, i3, CES, devcies that report data, ChinaGate, healthh insurance
-
If you are a patient you want something like this going on monitoring your care as the physician can log in anywhere in the hospital to check vitals and other specific conditions. We are talking blood coagulations and insulin levels here so again this goes beyond just the basics and comes into...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Oct 18 2010
Filed under:
Filed under: Technology, Pharma/FDA News, Hospital, drugs, Medical Devices, insulin, Genentech, Roche, Data, monitoring devices, Mergers and Acquisitions, networks, patient data, POC Informtion
-
This is big purchase and they are perhaps looking to anticipated reduced revenue once generic drugs for Lipitor come on line. We are seeing mergers and acquisitions all over healthcare. Below are some of the leading pain killers from King Pharma and the company also has quite a few other...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Oct 14 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Pharma, FDA, Pfizer, Mergers and Acquisitions, pain killers, King Pharmaceuticals
-
The bigger pharma companies continue with acquisitions and FoldRX focuses on niche disease cures in the neurological area. Next year is when the patent expires for Lipitor and the company is looking for ways to replace lost revenue that will occur when generics become available. BD ...
-
The cost of the purchase will help offset what is perhaps being spent outside the company for research and development with drugs and devices. If a company does not have internal resources it has to outsource and find a company that can provide that the FDA is looking related to regulation. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Aug 16 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Medco, Mergers and Acquisitions, Pharmacy Benefit manager, United Biosource Corp